Clinical Study
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
Table 3
Adverse events of 7-day concomitant therapy.
| Adverse events | 7-day concomitant therapy group () |
| Abdominal pain | 3 (1/1/1*) | Constipation | 2 (1/0/1) | Diarrhea | 2 (1/0/1) | Dizziness | 0 (0/0/0) | Headache | 11 (7/2/2) | Nausea/vomiting | 26 (14/9/3) | Taste perversion | 5 (3/1/1) | Palpitation | 3 (2/1/0) | Insomnia | 3 (1/1/1) | Other | 21 (13/4/4) |
|
|
*
Number of patients who suffered from mild, moderate, and severe adverse events.
|